Pathogenesis and Treatment of Glucocorticoid-Induced Osteoporosis

ISSN： 1170-229X

Source： Drugs & Aging, Vol.12, Iss.6, 1998-06, pp. : 477-484

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The prevention and treatment of glucocorticoid-induced osteoporosis in clinical practice

By Walker-Bone Karen Wood Angela Hull Richard Ledingham Joanna M McCrae Fiona C Shaban Ragai Thomas Alastair Mackay Kirsten

Clinical Medicine, Vol. 4, Iss. 5, 2004-09 ,pp. : 431-436

Royal College Of Physicians

Access to resources Recommend Favorite

Prevention of glucocorticoid-induced osteoporosis

By van Brussel MS Bultink IEM Lems WF

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. : 997-1005

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic patenting for glucocorticoid-induced osteoporosis

By Cooper M.S. Stewart P.M.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 6, 2000-06 ,pp. : 847-857

Informa Healthcare

Access to resources Recommend Favorite

Paediatric patients at risk for glucocorticoid-induced osteoporosis benefit from treatment with alendronic acid

Reactions Weekly, Vol. 1, Iss. 1182, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions

By Bultink Irene EM Baden Marijke Lems Willem F

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 2, 2013-02 ,pp. : 185-197

Informa Healthcare

Access to resources Recommend Favorite